HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Interleukin-6 induces malignant transformation of rat mesenchymal stem cells in association with enhanced signaling of signal transducer and activator of transcription 3.

Abstract
Mesenchymal stem cells (MSCs) have the potential to be the source for cell-based therapies. However, MSCs can undergo malignant transformation in a tumor microenvironment where a high level of interleukin (IL)-6 is present. In this study, we investigated the role of IL-6 and signal transducer and activator of transcription 3 (STAT3) signaling in malignant transformation of MSCs. Rat MSCs were isolated and indirectly cocultured with C6 glioma cells. Coculture of MSCs with astrocytes was used as a control. After 7 days of culture, the cells were assessed for malignant transformation using MTT assay and immunofluorescence staining. The levels of hepatocyte growth factor, IL-6, and basic fibroblast growth factor, and the expression of STAT3 and soluble IL-6 receptor in the cultured cells and conditioned media were measured using RT-PCR, ELISA, and Western blot analysis. The expression levels of STAT3 downstream targets, CyclinD1 and Bcl-xl, were determined as well. Our data showed that almost all of the MSCs became phenotypically malignant after indirect coculture with glioma cells, which was confirmed by tumor formation assays when these cells were injected into nude mice. The expression of IL-6 was significantly increased in MSCs cocultured with glioma cells, which was associated with significantly increased expressions of soluble IL-6 receptor, transmembrane glycoprotein GP130, STAT3, phosphorylated STAT3, CyclinD1, and Bcl-xl. Similar results were obtained when the MSCs were treated with IL-6. Treatment of the cocultured MSCs and glioma cells with STA-21, to block the constitutive STAT3 signaling, reduced the risk of MSC tumor-like transformation in the tumor microenvironment. These data suggest that IL-6 plays a critical role in malignant transformation of rat MSCs, which is associated with an enhancement of the STAT3 signaling pathway in the tumor microenvironment.
AuthorsXiangrong Cui, Jianping Liu, Lu Bai, Jie Tian, Jing Zhu
JournalCancer science (Cancer Sci) Vol. 105 Issue 1 Pg. 64-71 (Jan 2014) ISSN: 1349-7006 [Electronic] England
PMID24168060 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2013 The Authors. Cancer Science published by Wiley Publishing Asia Pty Ltd on behalf of Japanese Cancer Association.
Chemical References
  • Culture Media, Conditioned
  • Interleukin-6
  • STAT3 Transcription Factor
  • Stat3 protein, rat
  • Fibroblast Growth Factors
  • Janus Kinases
Topics
  • Animals
  • Astrocytes (cytology)
  • Cell Line, Tumor
  • Cell Transformation, Neoplastic (genetics, metabolism, pathology)
  • Coculture Techniques
  • Culture Media, Conditioned
  • Fibroblast Growth Factors
  • Glioma (genetics, metabolism, pathology)
  • Interleukin-6 (genetics, metabolism)
  • Janus Kinases (metabolism)
  • Male
  • Mesenchymal Stem Cells (metabolism, pathology)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Rats
  • Rats, Wistar
  • STAT3 Transcription Factor (genetics, metabolism)
  • Signal Transduction
  • Tumor Microenvironment

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: